Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comprehensive HIV and Harm Prevention Via Telehealth
Sponsor: University of Miami
Summary
The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.
Official title: Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
350
Start Date
2024-10-07
Completion Date
2028-05-31
Last Updated
2026-02-17
Healthy Volunteers
No
Conditions
Interventions
Comprehensive Tele-harm Reduction
Comprehensive Tele-Harm Reduction is on-demand services including low-barrier access to PrEP, medications for substance use disorder and hepatitis C treatment. It includes mobile phlebotomy, peer harm reduction counseling, medication management, telehealth mental health/substance use disorder services-- all delivered via an syringe services program.
Off-site Linkage to HIV Prevention
The community engagement team is comprised of peers and social workers and provides the wraparound support needed.The team will assist participants in scheduling appointments at community health clinics. The community engagement team provides active clinic referral- that is, a member of the team will accompany patients to the first clinic visit.
Locations (2)
IDEA Miami
Miami, Florida, United States
IDEA Syringe Services Program
Miami, Florida, United States